• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Acumen Pharmaceuticals, Inc. - Common Stock (NQ:ABOS)

    2.775 +0.005 (+0.18%)
    Streaming Delayed Price Updated: 10:47 AM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Acumen Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    News headline image
    How Is The Market Feeling About Acumen Pharmaceuticals? ↗
    Acumen Pharmaceuticals's (NASDAQ:ABOS) short percent of float has risen 237.39% since its last report. The company recently reported that it has 2.36 million shares sold short, which is 7.76% of all... 
    Via Benzinga
    News headline image
    RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday ↗
    U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    News headline image
    Bank of America To $36? Plus This Analyst Slashes PT On Citigroup ↗
    Morgan Stanley cut Bank of America Corporation (NYSE: BAC) price target from $40 to $36. Bank of America shares fell 2.4% to $31.62 on Wednesday. 
    Via Benzinga
    News headline image
    Netflix, Biogen And Other Big Gainers From Wednesday ↗
    U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session. 
    Via Benzinga
    News headline image
    Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗
    Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
    Via Benzinga
    News headline image
    These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗
     
    Via Benzinga
    News headline image
    Nasdaq Surges Over 150 Points; Gold Rises 2% ↗
    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Wednesday. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Why Is Prothena (PRTA) Stock Up 75% Today? ↗
    Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company. 
    Via InvestorPlace
    News headline image
    Why Is Acumen (ABOS) Stock Up 95% Today? ↗
    Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company. 
    Via InvestorPlace
    News headline image
    Dow Jumps 300 Points; Crude Oil Rises Sharply ↗
    U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday. 
    Via Benzinga
    News headline image
    Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Why Acumen Pharmaceuticals Stock Is Soaring Today ↗
    Acumen Pharmaceuticals Inc (NASDAQ: ABOS) shares are trading higher Wednesday after Biogen Inc (NASDAQ: BIIB) and Eisai Co (Pink: 
    Via Benzinga
    News headline image
    US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗
    U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million. 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. 
    Via InvestorPlace
    News headline image
    Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗
    Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
    Via Benzinga
    News headline image
    Recap: Acumen Pharmaceuticals Q2 Earnings ↗
      Acumen Pharmaceuticals (NASDAQ:ABOS) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    News headline image
    Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences
    From Acumen Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday ↗
    Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
    Via Benzinga
    News headline image
    Earnings Scheduled For August 15, 2022 ↗
    Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 ↗
      
    Via Benzinga
    News headline image
    A Tale of Tangles Chapter Three: The Desert Expanse ↗
    Source: © Sergey Pesterev / Wikimedia Commons / CC BY-SA 4.0 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Wednesday ↗
    On Wednesday, 29 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    Earnings Scheduled For March 28, 2022 ↗
    Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Friday ↗
    On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
    On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.